WITHDRAWN: Irinotecan plus Weekly 5-Fluorouracil and Leucovorin as Salvage Treatment for Patients with Metastatic Colorectal Cancer: A Phase II Trial

Digestive Diseases ◽

10.1159/000099177 ◽

2007 ◽

Vol 25 (1) ◽

pp. 100-105 ◽

Author(s):

J. Souglakos ◽

N. Vardakis ◽

N. Androulakis ◽

S. Kakolyris ◽

C. Kourousis ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Salvage Treatment

Download Full-text

Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-014-2515-8 ◽

2014 ◽

Vol 74 (3) ◽

pp. 447-455 ◽

Author(s):

Keun-Wook Lee ◽

Yu Jung Kim ◽

Kyung-Hun Lee ◽

Sae-Won Han ◽

Tae-Yong Kim ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Salvage Treatment

Download Full-text

A Phase II Trial of Salvage Treatment with Gemcitabine and S-1 Combination in Heavily Pretreated Patients with Metastatic Colorectal Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)32467-4 ◽

2012 ◽

Vol 23 ◽

pp. xi151-xi152

Author(s):

S.J. Sym ◽

J. Hong ◽

M. Jung ◽

J. Park ◽

E.K. Cho ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Salvage Treatment ◽

Heavily Pretreated ◽

Pretreated Patients

Download Full-text

Faculty Opinions recommendation of A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697918.793457734 ◽

2012 ◽

Author(s):

Hans-Joachim Schmoll

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

172PD Final analysis: Phase II trial of irinotecan/S-1/cetuximab (IRIS/Cet) as second line treatment in patients with KRAS exon2 wild type metastatic colorectal cancer: HGCSG0902. Comparison of administration interval in cetuximab treatment

Annals of Oncology ◽

10.1016/s0923-7534(21)00330-6 ◽

2016 ◽

Vol 27 ◽

pp. ix54

Author(s):

T. Ando ◽

S. Yuki ◽

H. Nakatsumi ◽

T. Muranaka ◽

A. Hosokawa ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Final Analysis ◽

Line Treatment ◽

Second Line ◽

Wild Type ◽

Analysis Phase ◽

Administration Interval

Download Full-text

A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.13511 ◽

2021 ◽

Author(s):

Mingzhu Huang ◽

Yue Yang ◽

Xiaodong Zhu ◽

Zhiyu Chen ◽

Wen Zhang ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Salvage Treatment ◽

Prospective Phase

Download Full-text

A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer

European Journal of Cancer ◽

10.1016/j.ejca.2014.08.008 ◽

2014 ◽

Vol 50 (18) ◽

pp. 3136-3144 ◽

Author(s):

Tamas Hickish ◽

Jim Cassidy ◽

David Propper ◽

Ian Chau ◽

Stephen Falk ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Open Label Phase

Download Full-text

A Randomized Phase II Trial of Pemetrexed plus Irinotecan (ALIRI) versus Leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in First-Line Treatment of Locally Advanced or Metastatic Colorectal Cancer

Oncology ◽

10.1159/000120626 ◽

2007 ◽

Vol 73 (1-2) ◽

pp. 9-20 ◽

Author(s):

Craig Underhill ◽

David Goldstein ◽

Vera A. Gorbounova ◽

Mikhail Y. Biakhov ◽

Igor S. Bazin ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Multicenter randomized phase II trial (BEVATOMOX) assessing the raltitrexed, oxaliplatin and bevacizumab combination versus FOLFOX6 bevacizumab as 2nd line treatment in metastatic colorectal cancer (mCRC)

Annals of Oncology ◽

10.1093/annonc/mdx393.055 ◽

2017 ◽

Vol 28 ◽

pp. v179

Author(s):

E. Samalin ◽

H. Senellart ◽

S. Thezenas ◽

S. Jacquot ◽

S. Ellis ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Randomized Phase Ii

Download Full-text

Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype

British Journal of Cancer ◽

10.1038/s41416-018-0348-7 ◽

2018 ◽

Vol 120 (2) ◽

pp. 190-195 ◽

Author(s):

David Páez ◽

María Tobeña ◽

Julen Fernández-Plana ◽

Ana Sebio ◽

Anna C. Virgili ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

High Dose ◽

Efficacy And Safety ◽

Colorectal Cancer Patients

Download Full-text

Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer

Investigational New Drugs ◽

10.1007/s10637-010-9418-2 ◽

2010 ◽

Vol 29 (5) ◽

pp. 1073-1080 ◽

Author(s):

Sang Joon Shin ◽

Jae Heon Jeong ◽

Young Suk Park ◽

Kyung Hee Lee ◽

Byoung Yong Shim ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Download Full-text